-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Reduced exercise capacity in persons with Down syndrome: cause, effect, and management
Review
(1574) Views (390) Full article downloads
Authors: Goncalo V Mendonca, Fernando D Pereira1 Bo Fernhall
Published Date December 2010
Volume 2010:6 Pages 601 - 610
DOI: http://dx.doi.org/10.2147/TCRM.S10235
Goncalo V Mendonca1, Fernando D Pereira1, Bo Fernhall21Center of Human Performance (CIPER), Faculty of Human Kinetics, Technical University of Lisbon, Lisbon, Portugal; 2Kinesiology and Community Health, University of Illinois at Urbana Champaign, Champaign, IL, USA
Abstract: Persons with Down syndrome (DS) have reduced peak and submaximal exercise capacity. Because ambulation is one predictor of survival among adults with DS, a review of the current knowledge of the causes, effects, and management of reduced exercise capacity in these individuals would be important. Available data suggest that reduced exercise capacity in persons with DS results from an interaction between low peak oxygen uptake (VO2peak) and poor exercise economy. Of several possible explanations, chronotropic incompetence has been shown to be the primary cause of low VO2peak in DS. In contrast, poor exercise economy is apparently dependent on disturbed gait kinetics and kinematics resulting from joint laxity and muscle hypotonia. Importantly, there is enough evidence to suggest that such low levels of physical fitness (reduced exercise capacity and muscle strength) limit the ability of adults with DS to perform functional tasks of daily living. Consequently, clinical management of reduced exercise capacity in DS seems important to ensure that these individuals remain productive and healthy throughout their lives. However, few prospective studies have examined the effects of structured exercise training in this population. Existent data suggest that exercise training is beneficial for improving exercise capacity and physiological function in persons with DS. This article reviews the current knowledge of the causes, effects, and management of reduced exercise capacity in DS. This review is limited to the acute and chronic responses to submaximal and peak exercise intensities because data on supramaximal exercise capacity of persons with DS have been shown to be unreliable.
Keywords: Down syndrome, peak exercise capacity, exercise economy, ventilatory threshold, exercise training
Readers of this article also read:
Capsule endoscopy in clinical practice: concise up-to-date overview
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
Development and implementation of an online hybrid model for teaching evidence-based practice to health professions: processes and outcomes from an Australian experience
The economic impact of obesity in the United States
Effect of HIV infection on time to recovery from an acute manic episode
Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgery
Interprofessional education: a concept analysis
Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




